Remove 2009 Remove Clinical Trials Remove Sleep
article thumbnail

5 Things Veterans Deserve to Know About Medical Marijuana

CannaMD

A 2009 Canadian clinical trial of synthetic cannabinoid medication, nabilone , found: The majority of patients (72%) receiving nabilone experienced either cessation of nightmares or a significant reduction in nightmare intensity. Medical marijuana may also play a role in treating nightmares.

article thumbnail

Cannabis Industry Leaders Speak With CLR on Current Delta 8 Issues In The Industry

Cannabis Law Report

D8 may well assist with relaxation and sleep. The slight “high” seems to be part of the appeal but the relaxation and sleep benefits also carry broad appeal as well. They also sleep better and aren’t as bothered by “Musculo-Skeletal Discomfort”. Do you think there would be such a fuss about 8 if it didn’t get people “high”? .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

It became illegal in the US in 2009. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine.

History 119
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. But the research wasn’t enough.

CBD 40
article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. ” Underground researcher. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

Some patients put faith in anecdotal reports or the encouraging results of observational studies, but anecdotal reports and observational studies are not double blind randomized controlled clinical trials and do not prove that a treatment is or is not effective.

article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

The ECS touches on nearly every biological function you have, including sleep, pain, appetite, body temperature, immune function, memory, and hormone regulation. 3 A 2009 study touched on the trigeminal system as well, examining the connection between the CB1 gene (called CNR1) and people who reported migraines.

Terpenes 132